Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Feb 13:16:1479183.
doi: 10.3389/fneur.2025.1479183. eCollection 2025.

Neuroimaging advances in neurocognitive disorders among HIV-infected individuals

Affiliations
Review

Neuroimaging advances in neurocognitive disorders among HIV-infected individuals

Han Wang et al. Front Neurol. .

Abstract

Although combination antiretroviral therapy (cART) has been widely applied and effectively extends the lifespan of patients infected with human immunodeficiency virus (HIV), these patients remain at a substantially increased risk of developing neurocognitive impairment, commonly referred to as HIV-associated neurocognitive disorders (HAND). Magnetic resonance imaging (MRI) has emerged as an indispensable tool for characterizing the brain function and structure. In this review, we focus on the applications of various MRI-based neuroimaging techniques in individuals infected with HIV. Functional MRI, structural MRI, diffusion MRI, and quantitative MRI have all contributed to advancing our comprehension of the neurological alterations caused by HIV. It is hoped that more reliable evidence can be achieved to fully determine the driving factors of cognitive impairment in HIV through the combination of multi-modal MRI and the utilization of more advanced neuroimaging analysis methods.

Keywords: HIV-associated neurocognitive disorders; diffusion magnetic resonance imaging; functional magnetic resonance imaging; quantitative magnetic resonance imaging; structural magnetic resonance imaging.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Similar articles

References

    1. Deeks SG, Lewin SR, Havlir DV. The end of AIDS: HIV infection as a chronic disease. Lancet. (2013) 382:1525–33. 10.1016/S0140-6736(13)61809-7 - DOI - PMC - PubMed
    1. Frescura L, Godfrey-Faussett P, Feizzadeh AA, El-Sadr W, Syarif O, Ghys PD. Achieving the 95 95 95 targets for all: a pathway to ending AIDS. PLoS One. (2022) 17:e0272405. 10.1371/journal.pone.0272405 - DOI - PMC - PubMed
    1. Wallace DR. HIV-associated neurotoxicity and cognitive decline: therapeutic implications. Pharmacol Ther. (2022) 234:108047. 10.1016/j.pharmthera.2021.108047 - DOI - PubMed
    1. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, et al. . Updated research nosology for HIV-associated neurocognitive disorders. Neurology. (2007) 69:1789–99. 10.1212/01.WNL.0000287431.88658.8b - DOI - PMC - PubMed
    1. Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, Leblanc S, et al. . HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol. (2011) 17:3–16. 10.1007/s13365-010-0006-1 - DOI - PMC - PubMed

LinkOut - more resources